Login
Home
Charts
Search
Watchlist
Products

Indrayani Biotech Ltd

INDRANIB·BSE
₹9.14+2.12%Tue, 22 Sept '26 11:56
Industry:Diversified
Indices:

Indrayani Biotech Ltd

INDRANIB
BSE
₹9.14
+2.12%
|Tue, 22 Sept '26 11:56
SOICxStockScans Reports
Industry
Diversified
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹71Cr
Close
Close Price
₹9.14
Industry
Industry
Diversified
PE
Price To Earnings
21.76
PS
Price To Sales
0.52
Revenue
Revenue
₹138Cr
Rev Gr TTM
Revenue Growth TTM
5.84%
PAT Gr TTM
PAT Growth TTM
135.35%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
424039443231175129363538
Growth YoY
Revenue Growth YoY%
65.1-3.8-15.0-9.9-25.5-23.8-55.713.9-7.716.7102.1-25.3
Expenses
ExpensesCr
403336342623145630343236
Operating Profit
Operating ProfitCr
37310673-6-1232
OPM
OPM%
6.018.18.822.919.023.816.9-11.3-1.86.87.95.8
Other Income
Other IncomeCr
000100031211
Interest Expense
Interest ExpenseCr
211611172223
Depreciation
DepreciationCr
1111431-21111
PBT
PBTCr
0615110-8010-1
Tax
TaxCr
00000000000-2
PAT
PATCr
0615110-90101
Growth YoY
PAT Growth YoY%
-125.15.3-68.6228.5288.9-78.0-67.6-280.3-81.2-25.4-65.7111.5
NPM
NPM%
-1.113.72.810.72.74.02.0-16.90.62.50.32.6
EPS
EPS₹
-0.11.00.20.60.10.10.1-2.10.00.10.00.3
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
424039443231175129363538
Growth YoY
Revenue Growth YoY%
65.1-3.8-15.0-9.9-25.5-23.8-55.713.9-7.716.7102.1-25.3
Expenses
ExpensesCr
403336342623145630343236
Operating Profit
Operating ProfitCr
37310673-6-1232
OPM
OPM%
6.018.18.822.919.023.816.9-11.3-1.86.87.95.8
Other Income
Other IncomeCr
000100031211
Interest Expense
Interest ExpenseCr
211611172223
Depreciation
DepreciationCr
1111431-21111
PBT
PBTCr
0615110-8010-1
Tax
TaxCr
00000000000-2
PAT
PATCr
0615110-90101
Growth YoY
PAT Growth YoY%
-125.15.3-68.6228.5288.9-78.0-67.6-280.3-81.2-25.4-65.7111.5
NPM
NPM%
-1.113.72.810.72.74.02.0-16.90.62.50.32.6
EPS
EPS₹
-0.11.00.20.60.10.10.1-2.10.00.10.00.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
63958502162163166130138
Growth
Revenue Growth%
580.447.7-57.7192.0164.62.0-21.75.8
Expenses
ExpensesCr
63958472655146143124128
Operating Profit
Operating ProfitCr
0103-571723610
OPM
OPM%
2.41.80.75.6-23.511.010.614.14.87.0
Other Income
Other IncomeCr
0000-404135
Interest Expense
Interest ExpenseCr
0001226101210
Depreciation
DepreciationCr
0001013434
PBT
PBTCr
0001-1141211-60
Tax
TaxCr
000000010-2
PAT
PATCr
0001-1141210-62
Growth
PAT Growth%
33.8-39.9-1,489.0139.6168.7-12.6-158.6135.4
NPM
NPM%
-1.2-0.1-0.11.6-53.27.27.36.3-4.71.6
EPS
EPS₹
0.00.00.00.3-6.01.42.81.5-1.50.5
Financial YearMar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
63958502162163166130138
Growth
Revenue Growth%
580.447.7-57.7192.0164.62.0-21.75.8
Expenses
ExpensesCr
63958472655146143124128
Operating Profit
Operating ProfitCr
0103-571723610
OPM
OPM%
2.41.80.75.6-23.511.010.614.14.87.0
Other Income
Other IncomeCr
0000-404135
Interest Expense
Interest ExpenseCr
0001226101210
Depreciation
DepreciationCr
0001013434
PBT
PBTCr
0001-1141211-60
Tax
TaxCr
000000010-2
PAT
PATCr
0001-1141210-62
Growth
PAT Growth%
33.8-39.9-1,489.0139.6168.7-12.6-158.6135.4
NPM
NPM%
-1.2-0.1-0.11.6-53.27.27.36.3-4.71.6
EPS
EPS₹
0.00.00.00.3-6.01.42.81.5-1.50.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
444343434464646
Reserves
ReservesCr
00-3-15-1010182327
Current Liabilities
Current LiabilitiesCr
69141219728710293
Non Current Liabilities
Non Current LiabilitiesCr
0078736716558
Total Liabilities
Total LiabilitiesCr
1012514051156234268253
Current Assets
Current AssetsCr
471991978145178159
Non Current Assets
Non Current AssetsCr
6632313278899095
Total Assets
Total AssetsCr
1012514051156234268253
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
444343434464646
Reserves
ReservesCr
00-3-15-1010182327
Current Liabilities
Current LiabilitiesCr
69141219728710293
Non Current Liabilities
Non Current LiabilitiesCr
0078736716558
Total Liabilities
Total LiabilitiesCr
1012514051156234268253
Current Assets
Current AssetsCr
471991978145178159
Non Current Assets
Non Current AssetsCr
6632313278899095
Total Assets
Total AssetsCr
1012514051156234268253

Cash Flow

Consolidated
Standalone
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1260416-30-732
Investing Cash Flow
Investing Cash FlowCr
-30-4-1-1-47-1625-13
Financing Cash Flow
Financing Cash FlowCr
2-1-10-33344-18-15
Net Cash Flow
Net Cash FlowCr
011-112-204
Free Cash Flow
Free Cash FlowCr
-22303-5-47-8
CFO To PAT
CFO To PAT%
-1,879.2-2,578.4738.0-2.392.6135.7-291.2110.41,465.3
CFO To EBITDA
CFO To EBITDA%
126.0389.4214.7-5.260.794.0-129.5-107.7328.7
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1260416-30-732
Investing Cash Flow
Investing Cash FlowCr
-30-4-1-1-47-1625-13
Financing Cash Flow
Financing Cash FlowCr
2-1-10-33344-18-15
Net Cash Flow
Net Cash FlowCr
011-112-204
Free Cash Flow
Free Cash FlowCr
-22303-5-47-8
CFO To PAT
CFO To PAT%
-1,879.2-2,578.4738.0-2.392.6135.7-291.2110.41,465.3
CFO To EBITDA
CFO To EBITDA%
126.0389.4214.7-5.260.794.0-129.5-107.7328.7

Ratios

Consolidated
Standalone
Financial YearMar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2322104193224653371
Price To Earnings
Price To Earnings
3.823.522.235.115.221.8
Price To Sales
Price To Sales
8.40.11.01.71.21.40.50.20.5
Price To Book
Price To Book
-2.911.91.14.34.43.50.90.50.6
EV To EBITDA
EV To EBITDA
5.5-7.418.015.114.332.216.320.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
4.93.633.022.232.232.536.830.9
OPM
OPM%
2.41.80.75.6-23.511.010.614.14.87.07.0
NPM
NPM%
-1.2-0.1-0.11.6-53.27.27.36.3-4.71.61.6
ROCE
ROCE%
7.26.414.0-26.214.715.611.92.94.94.9
ROE
ROE%
-1.3-1.9318.3-56.918.426.916.5-8.83.03.0
ROA
ROA%
-0.5-0.51.6-28.08.67.74.5-2.30.80.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2322104193224653371
Price To Earnings
Price To Earnings
3.823.522.235.115.221.8
Price To Sales
Price To Sales
8.40.11.01.71.21.40.50.20.5
Price To Book
Price To Book
-2.911.91.14.34.43.50.90.50.6
EV To EBITDA
EV To EBITDA
5.5-7.418.015.114.332.216.320.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
4.93.633.022.232.232.536.830.9
OPM
OPM%
2.41.80.75.6-23.511.010.614.14.87.07.0
NPM
NPM%
-1.2-0.1-0.11.6-53.27.27.36.3-4.71.61.6
ROCE
ROCE%
7.26.414.0-26.214.715.611.92.94.94.9
ROE
ROE%
-1.3-1.9318.3-56.918.426.916.5-8.83.03.0
ROA
ROA%
-0.5-0.51.6-28.08.67.74.5-2.30.80.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Indrayani Biotech Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/yn72hw7yw4f7witzgmbt3xok.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/the45qjvbakuw6eqbppj8nc5.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/l66ej17t0sew3aglkyv7agax.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/qtr559o76zokkcmt26hqg79v.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/x56vsvhhuv3k6sy5wk6ya1k8.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/9wgn3aroxy7v8xn4lwd08iia.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/kodjuvsdkz73qnkwtk2dw2ya.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/amsrxfbn91nlqz6bc3c4bqd2.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/uz9bglnb5i43oeuaa0pxv3wp.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/gto0xu054yq1zg5z99s9fm8j.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/qa1jdosgm9qsb19aaahsyoh2.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/umx7v7psysnvrg23oqni196i.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/yua4v2ka11w4hnbjeblpd6b0.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/vmqi0kkax2wn4c62dijzo4e0.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies